NASDAQ : NTLA
Intellia Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 13.23 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.85B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Intellia Therapeutics, Inc. (NTLA) reported revenue of 59.51M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 59.51M | 67.67M | 57.88M | 36.27M | 52.12M | 33.05M |
| Cost of Revenue | 282.32M | 324.45M | 406.91M | 435.07M | 419.98M | 229.81M |
| Gross Profit | -222.82M | -256.78M | -349.04M | -398.79M | -367.86M | -196.75M |
| Selling, General & Admin | 200.66M | 184.21M | 185.23M | 116.50M | 90.31M | 71.10M |
| Operating Expenses | 200.66M | 184.21M | 185.23M | 116.50M | 90.31M | 71.10M |
| Operating Income | -423.48M | -440.99M | -534.26M | -515.29M | -458.16M | -267.85M |
| Interest & Investment Income | 24.19M | 29.20M | 47.81M | 49.83M | 8.54M | 1.28M |
| Earnings From Equity Investments | -15.63M | -11.08M | -1.32M | |||
| EBT Excluding Unusual Items | -399.29M | -411.80M | -486.46M | -481.09M | -460.70M | -267.89M |
| Gain (Loss) on Sale of Investments | -688.00K | -899.00K | -32.56M | |||
| Other Unusual Items | -100.00K | -13.48M | ||||
| Pretax Income | -399.98M | -412.69M | -519.02M | -481.19M | -474.19M | -267.89M |
| Net Income | -399.98M | -412.69M | -519.02M | -481.19M | -474.19M | -267.89M |
| Net Income to Common | -399.98M | -412.69M | -519.02M | -481.19M | -474.19M | -267.89M |
| Shares Outstanding (Basic) | 119.60M | 108.38M | 98.85M | 88.77M | 76.97M | 70.89M |
| Shares Outstanding (Diluted) | 119.60M | 108.38M | 98.85M | 88.77M | 76.97M | 70.89M |
| EPS (Basic) | -3.34 | -3.81 | -5.25 | -5.42 | -6.16 | -3.78 |
| EPS (Diluted) | -3.34 | -3.81 | -5.25 | -5.42 | -6.16 | -3.78 |
| Free Cash Flow | -348.69M | -395.87M | -354.66M | -408.07M | -346.85M | -237.79M |
| Free Cash Flow Per Share | -2.92 | -3.65 | -3.59 | -4.60 | -4.51 | -3.35 |
| Operating Margin | -711.66% | -651.67% | -923.10% | -1,420.51% | -879.04% | -810.37% |
| Profit Margin | -672.16% | -609.85% | -896.77% | -1,326.51% | -909.78% | -810.49% |
| Free Cash Flow Margin | -585.97% | -584.99% | -612.78% | -1,124.94% | -665.46% | -719.41% |
| EBITDA | -414.40M | -431.22M | -523.98M | -506.31M | -450.59M | -260.96M |
| D&A For EBITDA | 9.08M | 9.77M | 10.29M | 8.98M | 7.57M | 6.89M |
| EBIT | -423.48M | -440.99M | -534.26M | -515.29M | -458.16M | -267.85M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 106.13M | 155.46M | 189.18M | 226.75M | 523.51M | 123.41M |
| Short-Term Investments | 331.63M | 294.42M | 412.33M | 685.48M | 669.12M | 625.28M |
| Cash & Short-Term Investments | 437.76M | 449.88M | 601.51M | 912.22M | 1.19B | 748.69M |
| Receivables | 7.32M | 9.47M | 8.52M | 36.46M | 3.77M | 2.03M |
| Prepaid Expenses | 82.75M | 68.36M | 29.83M | 47.55M | 20.41M | 18.58M |
| Other Current Assets | 2.10M | |||||
| Total Current Assets | 527.83M | 527.71M | 639.86M | 998.33M | 1.22B | 769.30M |
| Property, Plant & Equipment | 101.01M | 123.63M | 246.67M | 148.13M | 161.00M | 100.11M |
| Long-Term Investments | 212.48M | 177.71M | 287.09M | 136.39M | 126.59M | 420.29M |
| Other Long-Term Assets | 15.84M | 13.08M | 17.39M | 18.12M | 15.73M | 4.76M |
| Total Assets | 857.16M | 842.13M | 1.19B | 1.30B | 1.52B | 1.29B |
| Accounts Payable | 11.71M | 20.25M | 14.59M | 7.45M | 5.15M | 9.65M |
| Accrued Expenses | 44.33M | 49.86M | 55.35M | 60.13M | 60.88M | 43.31M |
| Current Portion of Leases | 23.34M | 26.48M | 20.25M | 18.60M | 16.68M | 9.11M |
| Current Unearned Revenue | 7.29M | 20.66M | 22.14M | 43.84M | 63.76M | |
| Other Current Liabilities | 6.89M | |||||
| Total Current Liabilities | 79.39M | 103.88M | 110.85M | 115.21M | 126.55M | 125.83M |
| Long-Term Leases | 50.07M | 66.85M | 189.95M | 96.75M | 114.02M | 64.91M |
| Long-Term Unearned Revenue | 18.26M | 38.85M | 19.93M | 63.48M | ||
| Other Long-Term Liabilities | 24.03M | |||||
| Total Liabilities | 129.46M | 170.73M | 319.06M | 250.81M | 284.53M | 254.22M |
| Common Stock | 14.00K | 12.00K | 10.00K | 9.00K | 9.00K | 7.00K |
| Additional Paid-In Capital | 3.52B | 3.26B | 3.05B | 2.71B | 2.42B | 1.75B |
| Retained Earnings | -2.79B | -2.59B | -2.18B | -1.66B | -1.18B | -703.00M |
| Comprehensive Income & Other | -1.03M | 1.03M | 605.00K | -2.26M | -7.46M | -2.63M |
| Total Common Equity | 727.71M | 671.39M | 871.96M | 1.05B | 1.24B | 1.04B |
| Shareholders' Equity | 727.71M | 671.39M | 871.96M | 1.05B | 1.24B | 1.04B |
| Total Liabilities & Equity | 857.16M | 842.13M | 1.19B | 1.30B | 1.52B | 1.29B |
| Total Debt | 73.41M | 93.33M | 210.20M | 115.35M | 130.70M | 74.02M |
| Net Cash (Debt) | 554.94M | 511.81M | 651.53M | 896.74M | 1.13B | 1.01B |
| Net Cash Per Share | 4.64 | 4.72 | 6.59 | 10.10 | 14.70 | 14.28 |
| Filing Date Shares Outstanding | 140.13M | 118.13M | 103.52M | 96.11M | 88.02M | 74.67M |
| Total Common Shares Outstanding | 140.02M | 116.32M | 102.03M | 93.00M | 87.10M | 74.49M |
| Working Capital | 448.44M | 423.83M | 529.01M | 883.12M | 1.09B | 643.47M |
| Book Value Per Share | 5.20 | 5.77 | 8.55 | 11.29 | 14.19 | 13.97 |
| Tangible Book Value | 727.71M | 671.39M | 871.96M | 1.05B | 1.24B | 1.04B |
| Tangible Book Value Per Share | 5.20 | 5.77 | 8.55 | 11.29 | 14.19 | 13.97 |
| Machinery | 71.16M | 71.97M | 67.58M | 56.33M | 43.34M | |
| Leasehold Improvements | 3.20M | 3.20M | 3.13M | 3.07M | 2.19M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -399.98M | -412.69M | -519.02M | -481.19M | -474.19M | -267.89M |
| Depreciation & Amortization | 15.23M | 15.92M | 10.29M | 8.98M | 7.57M | 6.89M |
| Loss (Gain) From Sale of Assets | 680.00K | 527.00K | -76.00K | 72.00K | -162.00K | |
| Asset Writedown & Restructuring Costs | 55.99M | |||||
| Loss (Gain) From Sale of Investments | -2.37M | -4.96M | -6.22M | -19.27M | 15.41M | 10.54M |
| Loss (Gain) on Equity Investments | 15.63M | 11.08M | 1.32M | |||
| Stock-Based Compensation | 67.90M | 80.22M | 154.27M | 134.05M | 91.40M | 47.01M |
| Other Operating Activities | 100.00K | 13.48M | ||||
| Change in Accounts Receivable | 4.03M | -951.00K | 27.94M | -32.69M | -1.74M | 99.00K |
| Change in Accounts Payable | 1.91M | 5.99M | 6.80M | 2.52M | -4.58M | 529.00K |
| Change in Unearned Revenue | -26.18M | -28.11M | -22.08M | -2.78M | -63.46M | -31.36M |
| Change in Other Net Operating Assets | -7.88M | -50.68M | -785.00K | -19.51M | 15.91M | 7.82M |
| Operating Cash Flow | -346.64M | -394.74M | -348.88M | -394.09M | -333.29M | -225.03M |
| Capital Expenditures | -2.04M | -1.13M | -5.78M | -13.98M | -13.56M | -12.76M |
| Sale of Property, Plant & Equipment | 90.00K | 150.00K | ||||
| Sale (Purchase) of Intangibles | -44.83M | |||||
| Investment in Securities | -46.52M | 229.16M | 131.34M | -17.36M | 218.55M | -538.02M |
| Investing Cash Flow | -48.47M | 228.03M | 125.57M | -31.35M | 160.31M | -550.78M |
| Issuance of Common Stock | 346.52M | 131.49M | 185.75M | 130.32M | 582.96M | 736.69M |
| Financing Cash Flow | 346.52M | 131.49M | 185.75M | 130.32M | 582.96M | 736.69M |
| Net Cash Flow | -48.59M | -35.22M | -37.57M | -295.11M | 409.98M | -39.12M |
| Free Cash Flow | -348.69M | -395.87M | -354.66M | -408.07M | -346.85M | -237.79M |
| Free Cash Flow Margin | -585.97% | -584.99% | -612.78% | -1,124.94% | -665.46% | -719.41% |
| Free Cash Flow Per Share | -2.92 | -3.65 | -3.59 | -4.60 | -4.51 | -3.35 |
| Levered Free Cash Flow | -249.83M | -233.29M | -133.38M | -268.21M | -256.18M | -69.57M |
| Unlevered Free Cash Flow | -249.83M | -233.29M | -133.38M | -268.21M | -256.18M | -69.57M |
| Change in Working Capital | -28.11M | -73.75M | 11.88M | -52.45M | -53.87M | -22.90M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.75B | 1.04B | 1.19B | 2.73B | 2.97B | 8.80B |
| Enterprise Value | 1.19B | 469.42M | 344.50M | 1.86B | 2.22B | 7.73B |
| Last Close Price | 12.47 | 8.99 | 11.66 | 30.49 | 34.89 | 118.24 |
| PS Ratio | 29.36 | 15.39 | 20.52 | 75.27 | 57.06 | 266.22 |
| PB Ratio | 2.40 | 1.55 | 1.36 | 2.60 | 2.41 | 8.46 |
| P/TBV Ratio | 2.40 | 1.55 | 1.36 | 2.60 | 2.41 | 8.46 |
| EV/Sales Ratio | 20.04 | 6.94 | 5.95 | 51.17 | 42.65 | 233.76 |
| Debt / Equity Ratio | 0.10 | 0.14 | 0.24 | 0.11 | 0.11 | 0.07 |
| Net Debt / Equity Ratio | -0.76 | -0.76 | -0.75 | -0.85 | -0.92 | -0.97 |
| Net Debt / EBITDA Ratio | 1.34 | 1.19 | 1.24 | 1.77 | 2.51 | 3.88 |
| Net Debt / FCF Ratio | 1.59 | 1.29 | 1.84 | 2.20 | 3.26 | 4.26 |
| Asset Turnover | 0.07 | 0.07 | 0.05 | 0.03 | 0.04 | 0.03 |
| Quick Ratio | 5.61 | 4.42 | 5.50 | 8.23 | 9.45 | 5.97 |
| Current Ratio | 6.65 | 5.08 | 5.77 | 8.66 | 9.62 | 6.11 |
| Return on Equity (ROE) | -55.44% | -53.48% | -54.01% | -42.10% | -41.67% | -34.19% |
| Return on Assets (ROA) | -30.14% | -27.11% | -26.80% | -22.83% | -20.35% | -16.99% |
| Return on Capital Employed (ROCE) | -54.40% | -59.70% | -49.50% | -43.50% | -32.90% | -22.90% |
| Earnings Yield | -26.82% | -39.63% | -43.70% | -17.62% | -15.95% | -3.04% |
| FCF Yield | -19.95% | -38.02% | -29.87% | -14.95% | -11.66% | -2.70% |
| Buyback Yield / Dilution | -16.63% | -9.64% | -11.35% | -15.33% | -8.57% | -26.63% |